Knowledge of the TNXB status in CAH will not only offer patients a better understanding of their symptomatology with the burden of the diagnosis of a second genetic disease, but also assures specific clinical management with a focus on preventing musculoskeletal manifestations and complications. The gene discussed is TNXB; the disease is congenital adrenal hyperplasia.